Table 3.
Antibiotic resistance profiles for Pseudomonas aeruginosa and Enterobacteriaceae at MEE from 2014 to 2021.
|
|
|
|
||||
|---|---|---|---|---|---|---|
| Antibacterial drug |
P. aeruginosa
|
Enterobacteriaceae |
||||
| No. tested | % NS | No. tested | % NS | |||
|
|
|
|
||||
| Aztreonam | 213 | 6.6 | 165 | 7.9 | ||
| Amp/Sul | - | ND | 166 | 55.4 | ||
| Ceftazidime | 213 | 2.8 | 166 | 9.6 | ||
| Ceftriaxone | - | ND | 163 | 11.7 | ||
| Cefepime | 213 | 2.8 | 165 | 1.8 | ||
| Imipenem | 210 | 3.8 | 147 | 4.8 | ||
| Ciprofloxacin | 212 | 5.7 | 163 | 7.4 | ||
| Levofloxacin | 212 | 5.2 | 166 | 6.6 | ||
| Amikacin | 213 | 0.9 | 164 | 0.6 | ||
| Tobramycin | 212 | 2.4 | 165 | 6.7 | ||
| Gentamicin | 211 | 4.7 | 164 | 5.5 | ||
| TMP/SMX | - | ND | 165 | 10.3 | ||
NS: non-susceptible
ND: not-determined